The Effect of Phloroglucinol in Patients With Diarrhea-predominant Irritable Bowel Syndrome:  A Randomized, Double-blind, Placebo-controlled Trial

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Faculty Opinions recommendation of Linaclotide for irritable bowel syndrome with constipation: a 26-week, randomized, double-blind, placebo-controlled trial to evaluate efficacy and safety.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717958672.793516776 ◽

2016 ◽

Author(s):

Robin Spiller

Keyword(s):

Controlled Trial ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

The effect of Clostridium butyricum on symptoms and fecal microbiota in diarrhea-dominant irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial

Scientific Reports ◽

10.1038/s41598-018-21241-z ◽

2018 ◽

Vol 8 (1) ◽

Cited By ~ 16

Author(s):

Yi-Yuan Sun ◽

Ming Li ◽

Yue-Yue Li ◽

Li-Xiang Li ◽

Wen-Zhe Zhai ◽

...

Keyword(s):

Controlled Trial ◽

Fecal Microbiota ◽

Clostridium Butyricum ◽

Double Blind ◽

Double Blind Placebo ◽

S1298 AST-120 (Spherical Carbon Adsorbent) Improves Pain and Bloating in a Randomized, Double-Blind, Placebo-Controlled Trial in Patients With Non-Constipating Irritable Bowel Syndrome (IBS)

Gastroenterology ◽

10.1016/s0016-5085(10)61014-1 ◽

2010 ◽

Vol 138 (5) ◽

pp. S-223 ◽

Cited By ~ 2

Author(s):

Jan F. Tack ◽

M.S. Harris ◽

Scott Proksch ◽

Jeffrey D. Bornstein ◽

Philip B. Miner

Keyword(s):

Controlled Trial ◽

Carbon Adsorbent ◽

Double Blind ◽

Double Blind Placebo ◽

Spherical Carbon ◽

A Prospective Double-Blind Placebo-Controlled Trial of Mosapride in Patients with Constipation-predominant Irritable Bowel Syndrome

The American Journal of Gastroenterology ◽

10.14309/00000434-201110002-01314 ◽

2011 ◽

Vol 106 ◽

pp. S501

Author(s):

Nabil Mansour ◽

Ola Ghaith ◽

Mustapha El-Halabi ◽

Ala Sharara

Keyword(s):

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Randomised double-blind placebo-controlled trial of aloe vera for irritable bowel syndrome

International Journal of Clinical Practice ◽

10.1111/j.1742-1241.2006.00980.x ◽

2006 ◽

Vol 60 (9) ◽

pp. 1080-1086 ◽

Cited By ~ 28

Author(s):

K. DAVIS ◽

S. PHILPOTT ◽

D. KUMAR ◽

M. MENDALL

Keyword(s):

Controlled Trial ◽

Aloe Vera ◽

Double Blind ◽

Double Blind Placebo ◽

Repeat treatment with rifaximin improves irritable bowel syndrome-related quality of life: a secondary analysis of a randomized, double-blind, placebo-controlled trial

Therapeutic Advances in Gastroenterology ◽

10.1177/1756283x17726087 ◽

2017 ◽

Vol 10 (9) ◽

pp. 689-699 ◽

Cited By ~ 7

Author(s):

Brooks D. Cash ◽

Mark Pimentel ◽

Satish S. C. Rao ◽

Leonard Weinstock ◽

Lin Chang ◽

...

Keyword(s):

Quality Of Life ◽

Controlled Trial ◽

Secondary Analysis ◽

Double Blind ◽

Double Blind Placebo ◽

Repeat Treatment ◽

Related Quality ◽

Effect of multispecies probiotics on irritable bowel syndrome: A randomized, double-blind, placebo-controlled trial

Journal of Gastroenterology and Hepatology ◽

10.1111/jgh.12322 ◽

2013 ◽

Vol 29 (1) ◽

pp. 52-59 ◽

Cited By ~ 80

Author(s):

Jun Sik Yoon ◽

Won Sohn ◽

Oh Young Lee ◽

Sang Pyo Lee ◽

Kang Nyeong Lee ◽

...

Keyword(s):

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo ◽

377 A Randomized, Double-Blind, Placebo-Controlled Trial with a Novel Dual Noradrenergic Reuptake Inhibitor (NARI) and 5-HT3 Antagonist: Results of a Phase II 8-Week Study in Female Patients with Diarrhea Predominant Irritable Bowel Syndrome (D-IBS)

Gastroenterology ◽

10.1016/s0016-5085(08)60240-1 ◽

2008 ◽

Vol 134 (4) ◽

pp. A-50 ◽

Cited By ~ 4

Author(s):

William G. Paterson ◽

Jonathon Springer ◽

Michael O'Mahony ◽

Richard P. Reynolds ◽

Subhas C. Ganguli ◽

...

Keyword(s):

Phase Ii ◽

Reuptake Inhibitor ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Female Patients ◽

Randomized double blind placebo-controlled trial ofSaccharomyces cerevisiaeCNCM I-3856 in irritable bowel syndrome: improvement in abdominal pain and bloating in those with predominant constipation

United European Gastroenterology Journal ◽

10.1177/2050640615602571 ◽

2015 ◽

Vol 4 (3) ◽

pp. 353-362 ◽

Cited By ~ 29

Author(s):

Robin Spiller ◽

Fanny Pélerin ◽

Amélie Cayzeele Decherf ◽

Corinne Maudet ◽

Béatrice Housez ◽

...

Keyword(s):

Abdominal Pain ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo ◽

The Efficacy of the Kampo Formula Keishikashakuyakuto for Irritable Bowel Syndrome: A Phase 3, Multicenter, Double-Blind, Placebo- Controlled, Randomized Controlled Trial

Journal of Clinical Trials ◽

10.4172/2167-0870.1000345 ◽

2018 ◽

Vol 08 (02) ◽

Cited By ~ 1

Author(s):

Takuma Higurashi ◽

Akiko Fuyuki ◽

Hidenori Ohkubo ◽

Hiroshi Iida ◽

Masahiko Inamori ◽

...

Keyword(s):

Randomized Controlled Trial ◽

Controlled Trial ◽

Phase 3 ◽

Double Blind ◽

Double Blind Placebo ◽

Randomized Controlled ◽